blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2827903

EP2827903 - POTENTIATING ANTIBODY-INDUCED COMPLEMENT-MEDIATED CYTOTOXICITY VIA PI3K INHIBITION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  06.01.2017
Database last updated on 08.10.2024
Most recent event   Tooltip06.01.2017Application deemed to be withdrawnpublished on 08.02.2017  [2017/06]
Applicant(s)For all designated states
Memorial Sloan Kettering Cancer Center
1275 York Avenue
New York, NY 10065 / US
[2015/05]
Inventor(s)01 / WU, Xiaohong
105-05 69th Avenue
Apt 301
Forest Hills, NY 11375 / US
02 / SCHOLZ, Wolfgang, W.
7192 Sherbourne Lane
San Diego, CA 92129 / US
03 / RAGUPATHI, Govind
303 E 60th St 35g
New York, NY 10022 / US
04 / LIVINGSTON, Philip, O.
89 Myrtle View Street
Bluffton, SC 29910 / US
 [2015/05]
Representative(s)Lee, Nicholas John, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[N/P]
Former [2015/05]Cornish, Kristina Victoria Joy, et al
Kilburn & Strode LLP
20 Red Lion Street
London WC1R 4PJ / GB
Application number, filing date13764228.614.03.2013
WO2013US31278
Priority number, dateUS201261614942P23.03.2012         Original published format: US 201261614942 P
[2015/05]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013142245
Date:26.09.2013
Language:EN
[2013/39]
Type: A1 Application with search report 
No.:EP2827903
Date:28.01.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 26.09.2013 takes the place of the publication of the European patent application.
[2015/05]
Search report(s)International search report - published on:US26.09.2013
(Supplementary) European search report - dispatched on:EP12.01.2016
ClassificationIPC:A61K39/395, A61K39/00, A61K39/385, A61K39/39, A61K31/4375, A61K31/4745, A61K31/5377, C07K16/28, C07K16/30, C12Q1/68, G01N33/574, A61P35/00
[2015/43]
CPC:
A61K39/39558 (EP,US); A61K31/4375 (EP,US); A61K31/4745 (EP,US);
A61K31/5377 (EP,US); A61K39/0011 (EP,US); A61K39/001124 (EP,US);
A61K39/00117 (EP,US); A61K39/001171 (EP,US); A61K39/001172 (EP,US);
A61K39/001173 (EP,US); A61K39/001194 (EP,US); A61K39/385 (US);
A61K39/39 (US); A61P35/00 (EP); C07K16/2887 (EP,US);
C07K16/3084 (EP,US); C12Q1/6886 (US); G01N33/57484 (US);
A61K2039/505 (EP,US); A61K2039/507 (EP,US); A61K2039/545 (EP,US);
C07K2317/73 (EP,US); C07K2317/94 (EP,US); C12Q2600/106 (US);
C12Q2600/16 (US); Y10T436/143333 (EP,US) (-)
C-Set:
A61K39/0011, A61K2300/00 (EP,US);
A61K39/39558, A61K2300/00 (US,EP)
Former IPC [2015/05]A61K39/395, A61K39/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/05]
TitleGerman:POTENZIERUNG EINER ANTIKÖRPERINDUZIERTEN KOMPLEMENTVERMITTELTEN ZYTOTOXIZITÄT MITTELS PI3K-HEMMUNG[2015/05]
English:POTENTIATING ANTIBODY-INDUCED COMPLEMENT-MEDIATED CYTOTOXICITY VIA PI3K INHIBITION[2015/05]
French:POTENTIALISATION DE LA CYTOTOXICITÉ À MÉDIATION PAR LE COMPLÉMENT INDUITE PAR UN ANTICORPS PAR L'INTERMÉDIAIRE D'UNE INHIBITION DE PI3K[2015/05]
Entry into regional phase22.10.2014National basic fee paid 
22.10.2014Search fee paid 
22.10.2014Designation fee(s) paid 
22.10.2014Examination fee paid 
Examination procedure22.10.2014Examination requested  [2015/05]
23.04.2015Amendment by applicant (claims and/or description)
09.08.2016Application deemed to be withdrawn, date of legal effect  [2017/06]
14.09.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2017/06]
Fees paidRenewal fee
27.03.2015Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.03.201604   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2011153488  (ONCOTHYREON INC [US], et al);
International search[Y]US2004151733  (LIVINGSTON PHILIP O [US], et al);
 [X]US2009136516  (TEDDER THOMAS F [US], et al);
 [X]US2010233164  (EBENS JR ALLEN J [US], et al);
 [X]US2011178070  (GONG XIANCHANG [US], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.